PSI CRO continues growth in Asia-Pacific
Since 1995, the contract research organization (CRO) PSI CRO has been a private company fully owned by its management. It has grown organically by developing new locations driven by clinical trial requests.
Kayt Leonard of PSI CRO told us, “Patients are in need all over the world, and that means clinical trials and our clients are operating all over the world. PSI is global because our mission is global.”
PSI CRO has been operating in India for several years, and having an official location will allow its team to serve clients in a more efficient manner, according to Leonard.
In 2017, PSI opened offices in Sydney, Australia, and Seoul, South Korea. It has offices across five continents.
Leonard furthered, “We don’t have a 1 year, 5-year, or 10-year hiring plan. We grow based off of the work that we conduct combined with the staff and resources we need in order to complete that work successfully for our clients.”
PSI was not able to comment if there are any current trials occurring in Bangalore.
